Epilepsy Trial, Recruiting NCT06321822 Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT06321822
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People of any age (children and adults) who have been diagnosed with epilepsy
  • People of any sex
  • People who are currently being seen at the pediatric or adult epilepsy and electroencephalography clinics at U.O.C. Neurophysiopathology - IRCCS Ca' Granda Fondazione Ospedale Maggiore Policlinico
  • Adults who are able to give their own consent, or children and adults who cannot consent independently but whose parents or legal guardians are able to provide consent on their behalf

Additional criteria for a specific part of the trial involving detailed genetic testing (exome analysis):

  • DNA samples must be available from the patient and both biological parents
  • Doctors must consider the person to have a high likelihood of receiving a positive genetic diagnosis (confirm with trial site)

Who may not be able to join:

  • People who were initially thought to have epilepsy but were later found to have a different condition during their diagnostic process
  • People (or their parents or legal guardians) who have declined to give consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Robertino Dilena, MD, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Phone: +390255032982

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Registry
ClinicalTrials.gov
Start date
2 August 2021
Est. completion
2 August 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Identification of the genetic cause in patients with clinically probable genetic epilepsy using WES

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov